Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0388120030120030213
Journal of Korean Society for the Study of Obesity
2003 Volume.12 No. 3 p.213 ~ p.219
Effect of Orlistat Therapy on Fat Mass and Abdominal Fat
Kim Sung-Yong

Whang Yong-Ha
Chung Nak-So
Bong Jeong-Min
Lee Ki-Young
Kim Yeun-Sun
Kim Hong-Kyu
Park Ie-Byung
Park Hye-Young
Yang Dal-Mo
Kang Moon-Ho
Abstract
Background : Orlistat proromotes weight loss by inhibiting gastrointestimal lipases, thus lowering absorption of dietary fat. This study is to examine the effect of orlistat on the change of body composition including abdominal fat distribution in obese people.

Methods: Thirty seven obese people with BMI (25 kg/§³ were orlistat (120 mg, tid) for 6 months. Before and after treatment, total, trunk and leg body fat masses were measured using dual energy X-ray absorptometry and abdominal fat distribution was determined using computed tomography.

Results: Of the total 37 people, twenty subjects who completed the study were included in the data analysis. BMI, body weight, hip and waist circumferences decreased significantly after 6 months. Total and trunk fat mass decreased significantly after treatment but leg fat mass, lean body mass and bone did not. Orlistat treatment reduced visceral fat area (187¡¾73 vs. 154¡¾51 §², p<0.01) without significant change in abdominal subcutaneous fat area. The percent reduction of visceral fat was greater than those of total and trunk fat mass (12%:5%:6%).

Conclusion: Weight loss after orlistat treatment was associated with beneficial changes in body composition including reduction of visceral fat.
KEYWORD
Orlistat, Fat mass, Intraabdominal fat
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø